Cash Flow from Operating Activities: A company's cash flows from operations.
Senti Biosciences, Inc. (SNTI) had Cash Flow from Operating Activities of $-36.57M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-18.13M |
|
-- |
|
-- |
|
$16.95M |
|
$-16.95M |
|
$-1.18M |
|
$-18.13M |
|
$-18.13M |
|
$-18.13M |
|
$-18.13M |
|
$-18.13M |
|
$-18.13M |
|
$-16.95M |
|
$-16.04M |
|
26.23M |
|
26.23M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$18.16M |
|
$18.69M |
|
$34.53M |
|
$52.69M |
|
$12.03M |
|
-- |
|
$32.54M |
|
$44.56M |
|
$8.12M |
|
$8.12M |
|
$8.12M |
|
26.29M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-36.57M |
$-0.18M |
|
$0.72M |
|
$51.81M |
|
$15.78M |
|
$-36.03M |
|
$4.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-223.20% |
|
-223.20% |
|
-34.40% |
|
-223.20% |
|
$0.31 |
|
$-1.40 |
|
$-1.39 |
|